Actinium 225 Labeled Anti-CEA Antibody (Ac225-DOTA-M5A) for the Treatment of CEA Producing Advanced or Metastatic Cancers

NCT05204147 · clinicaltrials.gov ↗

PHASE1

Phase

SUSPENDED

Status

20

Enrollment

OTHER

Sponsor class

Stopped Drug Availability

Conditions

Advanced Cancer
Metastatic Cancer

Interventions

DRUG: Actinium Ac 225-DOTA-anti-CEA Monoclonal Antibody M5A
PROCEDURE: Biospecimen Collection

Sponsor

City of Hope Medical Center

Collaborators

[object Object]